Migraine burden and costs in France: a nationwide claims database analysis of triptan users

Anne Donnet, Corinne Emery, Samia Aly, Bashar Allaf, Fanny Cayre, Nicolas Mahieu, Julie Gourmelen, Pierre Lévy and Francis Fagnani
Additional contact information
Anne Donnet: Neurologie, maladies neuro-musculaires [Hôpital de la Timone - APHM] - AMU - Aix Marseille Université - APHM - Assistance Publique - Hôpitaux de Marseille - TIMONE - Hôpital de la Timone [CHU - APHM]
Corinne Emery: CEMKA-EVAL - CEMKA-EVAL
Samia Aly: Novartis Pharma - Novartis Pharma
Bashar Allaf: Novartis Pharma - Novartis Pharma
Fanny Cayre: Novartis Pharma - Novartis Pharma
Nicolas Mahieu: Novartis Pharma - Novartis Pharma
Julie Gourmelen: CESP - Centre de recherche en épidémiologie et santé des populations - UVSQ - Université de Versailles Saint-Quentin-en-Yvelines - UP11 - Université Paris-Sud - Paris 11 - AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP) - Hôpital Paul Brousse - INSERM - Institut National de la Santé et de la Recherche Médicale
Pierre Lévy: LEDa - Laboratoire d'Economie de Dauphine - Université Paris Dauphine-PSL - PSL - Université Paris Sciences et Lettres
Francis Fagnani: CEMKA-EVAL - CEMKA-EVAL

Post-Print from HAL

Keywords: Migraine; triptans; cost; burden; France; claims database (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Published in Journal of Medical Economics, 2019, 22 (7), ⟨10.1080/13696998.2019.1590841⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-02272280

DOI: 10.1080/13696998.2019.1590841

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().